Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (181-190 of 258) with videos related to

Pageof 26
Sort By:
Cancer Research|February 12, 2005
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccineXianzheng Zhou, Do Youn Jun, Amy Morck Thomas, et al.
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Molecular Microbiology|July 27, 2012
The NsrR regulon in nitrosative stress resistance of Salmonella enterica serovar TyphimuriumJoyce E Karlinsey, Iel-Soo Bang, Lynne A Becker, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Cancer Research|January 8, 2000
MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyteM I Nishimura, D Avichezer, M C Custer, et al.
Journal of Immunological Methods|March 10, 1997
Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1Y Kawakami, J K Battles, T Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Microbiology Spectrum|June 2, 2022
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021Kento T Abe, Bhavisha Rathod, Karen Colwill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Pageof 26

Showing results (181-190 of 258) with videos related to

Sort By:
Pageof 26
Cancer Research|February 12, 2005
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccineXianzheng Zhou, Do Youn Jun, Amy Morck Thomas, et al.
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Molecular Microbiology|July 27, 2012
The NsrR regulon in nitrosative stress resistance of Salmonella enterica serovar TyphimuriumJoyce E Karlinsey, Iel-Soo Bang, Lynne A Becker, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Cancer Research|January 8, 2000
MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyteM I Nishimura, D Avichezer, M C Custer, et al.
Journal of Immunological Methods|March 10, 1997
Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1Y Kawakami, J K Battles, T Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Microbiology Spectrum|June 2, 2022
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021Kento T Abe, Bhavisha Rathod, Karen Colwill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Pageof 26